VAERS reports by lot

GSK Varicella/Shingles lot Z9RR4: VAERS reports

95 VAERS reports list lot Z9RR4 as a GSK Varicella/Shingles vaccine, received between 2018-06-12 and 2020-10-02. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
95
Reports
5%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction14034%
General / Systemic (non-local)8721%
Neurological4611%
Musculoskeletal4311%
Dermatological (non-injection-site)277%
Gastrointestinal246%
Cardiac / Cardiovascular174%
Allergic / Anaphylactic123%
Psychiatric / Neuropsychiatric61%
Respiratory31%
Autoimmune / Immune-mediated10%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania11
New York11
Massachusetts8
Michigan7
Florida6
Virginia5
Ohio5
North Carolina4
South Carolina4
Kansas3
Indiana3
New Jersey2

Reports by month received

2018-0637
2018-0734
2018-084
2018-095
2018-107
2018-122
2019-013
2019-021
2019-081
2020-101

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.